← All Adaptin Bio, INC filings

Adaptin Bio, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OQB
APTN
Adaptin Bio, INC
8-K: Adaptin Bio Opens Glioblastoma Trial for APTN-101
Adaptin Bio, Inc. has announced the opening of enrollment for a Phase 1 clinical trial of its BRiTE therapeutic, APTN-101, targeting glioblastoma.